Crypto Pulse

Moderna (MRNA) stock surged 177% on August 19 after the company and Merck announced positive Phase 3 results for an experimental personalized mRNA cancer therapy. Merck (MRK) climbed 12.6% as investors reassessed both the commercial opportunity for the treatment and the broader potential of combining mRNA technology with cancer immunotherapy.The treatment, intismeran autogene, is being developed by Moderna in combination with Merck's Keytruda for patients with high-risk melanoma whose tumors hav

Walmart (WMT) reports fiscal second-quarter 2027 earnings on August 20, putting one of the world's largest retailers at the center of the latest U.S. earnings calendar. According to Walmart's official earnings schedule, quarterly materials are expected at approximately 6 a.m. Central Time before management holds its earnings call at 7 a.m.Wall Street expects Walmart to report approximately $186.8 billion in revenue and $0.74 in adjusted earnings per share, while U.S. comparable sales are expecte

Semiconductor stocks have lost momentum after one of the strongest stretches of the 2026 AI trade. Micron Technology (MU) fell about 7% on August 18, Sandisk (SNDK) dropped roughly 9%, Nvidia (NVDA) declined 2.3%, and the Philadelphia Semiconductor Index lost about 5%. The weakness spread across memory, storage, GPUs and other parts of the AI hardware supply chain rather than remaining concentrated in one company.The immediate question is therefore broader than why Micron or Sandisk fell on a si

Key takeawaysMerck and Moderna announced that the Phase 3 INTerpath-001 trial of intismeran autogene plus Keytruda met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in 1,137 patients with completely resected stage IIB-IV melanoma, randomized 2:1 against Keytruda alone. It is the first positive Phase 3 readout for an individualized neoantigen therapy and for any mRNA-based cancer treatment, in a field that has produced very few a

Key takeawaysArthur Hayes announced that he is taking the CEO role at Flop Labs, which is building Flop Network and its native FLOP token, pitched as "food for your AI agent" and intended as the currency agents use to buy inference, compute and persistent memory. The launch carries no presale and no venture capital allocation, with a large-scale airdrop planned for Q4 2026 and the genesis block targeted for Q1 2027, meaning the token is scheduled to be distributed a full quarter before the chain

Key takeawaysUnitree Robotics opened on the Shanghai STAR Market, 629.44% above its issue price, briefly valuing the first humanoid robotics company to list in mainland China at about $66 billion, before closing at roughly $50 billion. The retail tranche was oversubscribed more than 8,000 times, a STAR Market record, with 9.8 million accounts competing for approximately 9.7 million shares against a freely circulating float near 7.4% of share capital. Founder Wang Xingxing's 121.4 million shares

I. Macro & Market Sentiment(Market Data)· BTC Price: $69,672 (24h +8.26%)· Funding Rate: +0.0087%· Fear & Greed Index: 56 (Neutral)(Key Events Ahead)· No major macro events tonightII. Trading Signals / Hotspots(BTC / ETH · Capital Inflows)· U.S. spot Bitcoin ETFs recorded single-day net inflows of $189.3 million, including $143.6 million into IBIT. Spot Ethereum ETFs recorded net inflows of $71.4 million, including $64.7 million into ETHA. Two consecutive days of net inflows signal the return of

Unitree Robotics delivered one of the most dramatic Chinese IPO debuts of 2026 on August 19. Shares of the humanoid robot maker, trading under 688836 on Shanghai’s STAR Market, closed at RMB 845, up approximately 460% from the RMB 150.80 IPO price. The stock opened even higher at RMB 1,100 before giving back part of its early gains during the session. Investors who followed the company before the listing can review the full Unitree IPO date and listing timeline.The first-day rally pushed Unitree

MicroStrategy, now known as Strategy, has long been known for its aggressive Bitcoin accumulation strategy and its near-total reluctance to sell. But recently, the company has made a notable shift in how it manages its massive Bitcoin holdings. Instead of treating BTC purely as a long-term reserve asset, Strategy is beginning to approach it as a tool for optimizing its capital structure and maintaining liquidity.The question many investors are now asking is: can this new strategy still have the

Executive SummaryCerebras Systems (NASDAQ:CBRS) fell 12.69% on Tuesday, August 18, 2026, closing at $220.01, even as the company unveiled its next-generation CS-4 AI accelerator at its flagship Supernova event.The CS-4 delivers up to 30 times faster inference than GPU-based systems, twice the speed of its CS-3 predecessor, and up to 10 times more throughput per watt.Cerebras and OpenAI jointly introduced Ultrafast mode, a new GPT-5.6 Sol service tier running at up to 14 times the speed of standa